DarioHealth has entered a $30 million multiyear contract with Sanofi to accelerate the commercial reach of its digital therapeutics. The chronic care company provides artificial-intelligence-powered digital health solutions for conditions including diabetes, hypertension, weight management, musculoskeletal and behavioral health, the latter two of which were added to its platform just last year.

Dive Brief: French healthcare company Sanofi struck a $30 million, five-year agreement with digital health company DarioHealth. The deal would give Dario access to Sanofi’s sales teams to market its existing products, and it would also integrate Sanofi’s products onto its platform. The funding is broken down into five phases, with Dario getting $8 million in the […]

Over the past few years, the digital health space has been rapidly expanding and drawing the attention of Big Pharma. Now, one company has grabbed Sanofi’s attention — and sealed a deal. New-York based DarioHealth announced it entered into a strategic alliance agreement with Sanofi’s US subsidiary in a multi-year, $30 million deal. The agreement […]